Bevacizumab, is a medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy.[20][18] For age-related macular degeneration it is given by injection into the eye (intravitreal). Bevacizumab was approved for medical use in the United States in 2004. It is on the World Health Organization’s List of Essential Medicines. It is listed for its use in treating eye disease.<\/p>\n
Vegzelma (bevacizumab-adcd), a biosimilar to Avastin\u00ae (bevacizumab), is a recombinant humanized monoclonal antibody that binds to vascular endothelial growth factor (VEGF), the key driver of vasculogenesis and angiogenesis, and inhibits the binding of VEGF to its receptors Flt-1 (VEGFR-1) and kinase insert domain receptor (VEGFR-2) on the surface of endothelial cells.<\/p>\n
Avastin is a vascular endothelial growth factor-specific angiogenesis inhibitor indicated for the treatment of metastatic colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, cervical cancer, platinum-resistant recurrent epithelial ovarian and fallopian tube or primary peritoneal cancer.<\/p>\n
If bevacizumab-adcd injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Vegzelma is indicated for the treatment of six types of cancer: metastatic colorectal cancer; recurrent or metastatic non-squamous non-small cell lung cancer (nsNSCLC); recurrent glioblastoma; metastatic renal cell carcinoma; persistent, recurrent, or metastatic cervical cancer; and epithelial ovarian, fallopian tube, or primary peritoneal cancer.<\/p>\n
Disease Indications-Colorectal Cancer, Gynaecological Cancer, Kidney Cancer, Liver Cancer, Lung Cancer If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cbevacizumab-adcd injection\u201d based on the information you provide.<\/p>\n
\nManufacturer-Celltrion Healthcare Hungary Kft
\nUsage-Injection: 100 mg\/4 mL (25 mg\/mL) or 400 mg\/16 mL (25 mg\/mL) in a single-dose vial
\nMedicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n